Biography:
She is currently a Ph.D. candidate in Ophthalmology at Zhejiang University School of Medicine (ZJUSM), under the esteemed supervision of Professor Ye Shen. Professor Shen is recognized as a pioneering figure in Asia for the introduction and development of the Implantable Collamer Lens (ICL) procedure.
Her research trajectory bridges clinical epidemiology and molecular mechanisms in myopia. During her Master's degree at ZJUSM, her primary focus was on investigating the impact of light environments on myopia epidemiology and evaluating the visual outcomes and quality following various refractive surgeries. These works provided a strong foundation in population health and clinical applications within ophthalmology.
Presently, her doctoral research delves deeper into the fundamental biology of myopia. She is dedicated to elucidating the role of retinal epigenetic alterations in the pathogenesis of myopia. Utilizing advanced molecular techniques, her work aims to uncover how epigenetic modifications within the retina contribute to the initiation and progression of myopia, seeking novel insights into its underlying mechanisms. This shift represents her commitment to understanding the root causes of this globally significant condition, complementing her prior clinical and epidemiological experience.
She is passionate about advancing ophthalmic knowledge, spanning from large-scale population studies to intricate molecular pathways, with the ultimate goal of contributing to improved strategies for myopia prevention and management.
Title : Targeting the ALKBH5-ERK1/2 epitranscriptomic axis: A novel therapeutic strategy for myopia intervention